Open access · OA
via OpenAlex
Biomarkers of Cardiovascular Disease
Circulation · 2006 · ▲ 1,202 citations
Abstract
C ardiovascular diseases (CVD) are the leading cause of morbidity and mortality in the United States. Subclinical disease culminates in overt CVD. The onset of CVD itself portends an adverse prognosis with greater risk of recurrent events, morbidity, and mortality. It is also increasingly clear that although clinical assessment is the keystone of patient management, such evaluation has its limitations. 9 -12 Clinicians have used additional tools to aid clinical assessment and to enhance their ability to identify the "vulnerable" patient at risk for CVD, as suggested by a recent National Institutes of Health (NIH) panel. Biomarkers are one such tool to better identify high-risk individuals, to diagnose disease conditions promptly and accurately, and to effectively prognosticate and treat patients with disease. This review provides an overview of the molecular basis of biomarker discovery and selection and the practical considerations that are a prerequisite to their clinical use.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1161/circulationaha.104.482570
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Vasan, R.S. (2006). Biomarkers of Cardiovascular Disease. <em>Circulation</em>. https://doi.org/10.1161/circulationaha.104.482570
Vancouver
Vasan RS. Biomarkers of Cardiovascular Disease. Circulation. 2006. doi:10.1161/circulationaha.104.482570.
BibTeX
@article{ramachandran2006Biomar,
title = {Biomarkers of Cardiovascular Disease},
author = {Ramachandran S. Vasan},
journal = {Circulation},
year = {2006},
doi = {10.1161/circulationaha.104.482570},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Associação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv 2026
Open access · US-GOV
Effectiveness of Community Physical Exercise Program in Chronic Disease (CPEP - Chronic Disease), a Clinical Randomized Controlled Trial
Frontiers in aging neuroscience 2026
Citation only
Translating blood-based biomarkers into Alzheimer's disease clinical practice: screening, diagnosis, and longitudinal monitoring.
Signal Transduction and Targeted Therapy 2023
Open access · CC-BY
Neoantigens: promising targets for cancer therapy
Frontiers in Sports and Active Living 2025
Open access · CC-BY
The need for trained graduates to promote exercise as a mode of preventative healthcare in the United Arab Emirates
Current Alzheimer Research 2019
Citation only
Biomarkers for Alzheimer’s Disease
The British Journal of Diabetes 2013
Open access · OA